Robert B. Ford is a business executive who serves as the President and CEO of Abbott Laboratories, a global healthcare company that specializes in the research, development, manufacturing, and marketing of a diverse range of healthcare products, including diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Please note that my knowledge is up-to-date only until September 2021, so some information may have changed since then.
Robert Ford joined Abbott in 1996 and held various leadership positions within the company before being appointed CEO. Some of the roles he held at Abbott include Senior Vice President of Diabetes Care, Senior Vice President of the company's medical device businesses, and Executive Vice President of Medical Devices. In October 2018, Ford was named President and COO (Chief Operating Officer) of Abbott, and he became the CEO in March 2020, succeeding Miles D. White.
Under Ford's leadership, Abbott has continued to focus on innovation and growth in the healthcare sector, with a strong emphasis on developing life-changing technologies to help people live healthier lives. During his tenure, Abbott has launched several breakthrough products, such as the FreeStyle Libre glucose monitoring system for people with diabetes and the Alinity family of diagnostic systems.
Robert Ford holds a Bachelor's degree in Communications from Boston College and a Master's degree in Business Administration (MBA) from the University of California, Los Angeles (UCLA). His leadership and contributions to the healthcare industry have been widely recognized, and he has been featured on several lists of top executives, including Fortune's "40 Under 40" and the "Most Influential People in Healthcare."
Comments